Statistical Resources for the Interpretation and Integration of Human Genetic Association Studies

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Technologies and Resources for Genetics".

Deadline for manuscript submissions: closed (31 December 2017) | Viewed by 6613

Special Issue Editors


E-Mail Website
Guest Editor
Departments of Epidemiology and Biostatistics, School of Public Health, Harvard University, Boston, MA 02119, USA

E-Mail
Guest Editor
Center for Genomic Medicine, Mass General Hospital, Boston, MA 02119, USA

Special Issue Information

Dear Colleagues,

Genome-wide association studies (GWAS) have advanced our understanding of the genetic architecture of human complex traits and have identified scores of novel susceptibility loci. While the ultimate goal of GWAS is to facilitate the translation of genetic research into clinical application, the path from sequence to biology is often complicated. Unlike Mendelian traits, the highly polygenic nature of most complex traits has rendered it challenging to pin down specific “core” genes and pathways, owing to reasons such as linkage disequilibrium (LD) of correlated SNPs, small effect sizes, and identified variants falling in regulatory regions of the genome.

Many statistical or bioinformatics methods have been developed to functionally characterize the associated loci following GWAS discovery, often in conjunction with the maturation of genome annotation projects (e.g., ENCODE, GTEx). These include integrating GWAS data with molecular phenotypes (e.g., gene expression, DNA methylation) or other -omics data to infer targets for functional follow-up; partitioning SNP-heritability by functional categories in disease-relevant tissues or cell types to discover heritability-enriched regions; examining cross-trait associations to detect pleiotropic SNPs implicating a common pathogenesis; and many more. Other efforts include the increasing use of polygenic risk scores to aid in phenotype prediction and stratification and Mendelian randomization to determine causal relationships between pairs of traits. Recently, machine learning approaches and network-based methods have also been proposed to construct gene regulatory networks. However, despite some promising results, most underlying biological consequences remains to be unraveled.

It has now been ten years since the first applications of GWAS, new discoveries, as well as new methodological challenges, will continue to accumulate as sample sizes increase and the sequencing technology advances. In the next decade, the focus will inevitably shift from variant discovery to functional genomics. In this special issue, we would like to feature a series of statistical and computational methods or tools, based on SNP data or summary statistics, that facilitate the interpretation and/or integration of GWAS findings towards a better understanding of biological mechanisms underpinning complex traits and disease development (e.g., TWAS, MR/causal inference, methods for multiple phenotypes, etc.). We welcome any original articles relating to, but not limited to, the topics described herein.

Dr. Liming Liang
Dr. Yen-Chen Anne Feng
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Genome-wide association studies (GWAS)
  • Human complex traits
  • Single nucleotide polymorphism (SNP)
  • Linkage disequilibrium (LD)
  • Polygenicity
  • Pleiotropy
  • Omics data integration
  • Post-GWAS functional characterization

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

807 KiB  
Article
Genetic Association between Amyotrophic Lateral Sclerosis and Cancer
by Y-h. Taguchi and Hsiuying Wang
Genes 2017, 8(10), 243; https://doi.org/10.3390/genes8100243 - 27 Sep 2017
Cited by 22 | Viewed by 6284
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. An ALS drug, Riluzole, has been shown to induce two different anticancer effects on hepatocellular carcinoma (HCC). In light of this finding, we explore the relationship between ALS and cancer, especially for HCC, from [...] Read more.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. An ALS drug, Riluzole, has been shown to induce two different anticancer effects on hepatocellular carcinoma (HCC). In light of this finding, we explore the relationship between ALS and cancer, especially for HCC, from the molecular biological viewpoint. We establish biomarkers that can discriminate between ALS patients and healthy controls. A principal component analysis (PCA) based unsupervised feature extraction (FE) is used to find gene biomarkers of ALS based on microarray gene expression data. Based on this method, 101 probes were selected as biomarkers for ALS with 95% high accuracy to discriminate between ALS patients and controls. Most of the genes corresponding to these probes are shown to be related to various cancers. These findings might provide a new insight for developing new therapeutic options or drugs for both ALS and cancer. Full article
Show Figures

Figure 1

Back to TopTop